INMB
Price
$1.94
Change
+$0.07 (+3.74%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
51.58M
14 days until earnings call
Intraday Buy/Sell Signals
ORMP
Price
$2.27
Change
-$0.09 (-3.81%)
Updated
Oct 15, 04:59 PM (EDT)
Capitalization
96.77M
30 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

INMB vs ORMP

Header iconINMB vs ORMP Comparison
Open Charts INMB vs ORMPBanner chart's image
INmune Bio
Price$1.94
Change+$0.07 (+3.74%)
Volume$3.14K
Capitalization51.58M
Oramed Pharmaceuticals
Price$2.27
Change-$0.09 (-3.81%)
Volume$582
Capitalization96.77M
INMB vs ORMP Comparison Chart in %
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INMB vs. ORMP commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INMB is a Hold and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (INMB: $1.88 vs. ORMP: $2.36)
Brand notoriety: INMB and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INMB: 39% vs. ORMP: 149%
Market capitalization -- INMB: $51.58M vs. ORMP: $96.77M
INMB [@Biotechnology] is valued at $51.58M. ORMP’s [@Biotechnology] market capitalization is $96.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INMB’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • INMB’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than INMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INMB’s TA Score shows that 5 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • INMB’s TA Score: 5 bullish, 3 bearish.
  • ORMP’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INMB is a better buy in the short-term than ORMP.

Price Growth

INMB (@Biotechnology) experienced а -4.08% price change this week, while ORMP (@Biotechnology) price change was -4.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +18.38%, and the average quarterly price growth was +83.19%.

Reported Earning Dates

INMB is expected to report earnings on Oct 29, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($96.8M) has a higher market cap than INMB($51.6M). ORMP YTD gains are higher at: -2.479 vs. INMB (-59.743). ORMP has higher annual earnings (EBITDA): -22.07M vs. INMB (-39.72M). ORMP has more cash in the bank: 97.9M vs. INMB (33.4M). INMB has less debt than ORMP: INMB (451K) vs ORMP (912K). ORMP has higher revenues than INMB: ORMP (2M) vs INMB (50K).
INMBORMPINMB / ORMP
Capitalization51.6M96.8M53%
EBITDA-39.72M-22.07M180%
Gain YTD-59.743-2.4792,410%
P/E RatioN/A20.91-
Revenue50K2M3%
Total Cash33.4M97.9M34%
Total Debt451K912K49%
FUNDAMENTALS RATINGS
INMB vs ORMP: Fundamental Ratings
INMB
ORMP
OUTLOOK RATING
1..100
5458
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
9251
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (67) in the Pharmaceuticals Other industry is in the same range as INMB (70) in the Biotechnology industry. This means that ORMP’s stock grew similarly to INMB’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as INMB (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to INMB’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as INMB (99) in the Biotechnology industry. This means that ORMP’s stock grew similarly to INMB’s over the last 12 months.

ORMP's Price Growth Rating (51) in the Pharmaceuticals Other industry is somewhat better than the same rating for INMB (92) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than INMB’s over the last 12 months.

ORMP's P/E Growth Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for INMB (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than INMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMBORMP
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
INMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BIOQ40.00N/A
N/A
BIOQUAL, Inc.
TAPM0.35N/A
N/A
Tapinator, Inc.
JTGPF1.90N/A
N/A
JUST GROUP PLC
STPGF1.43-0.05
-3.38%
Steppe Gold Limited
LYSDY14.12-1.12
-7.35%
Lynas Rare Earths Limited